此外，相关临床试验数据显示，P9菌株可促进体内农药残留的排出，减轻农药暴露引起的炎症反应。 产品另一核心菌株植物乳植杆菌CN2018源自江南大学研究，该菌株具有耐酸性，试验显示其对幽门螺 杆菌生长有抑制作用。这两项研究成果都已获得国家专利，而多项尖端科研成果与专利的加持，也为这 份年礼增添了一份沉甸甸的科学"含金量"。 除了顶级的科研与学术背书，江中P9益生菌还拥有深厚的"航天基因"。此前，江中P9益生菌正式获中 国航天基金会授予"中国航天事业合作伙伴"荣誉，这不仅是对其科研实力的认可，更是对其航天级严苛 品质的肯定。春节送礼，这样一份拥有太空科研背景且具备航天级品质保障的礼物，更能体现出送礼者 诚挚的心意。 随着春节的临近，挑选一份既有心意又显体面的年礼成为许多人的考量。近年来，大众的健康意识显著 提升，送礼的逻辑也从传统的"烟酒糖茶"转向了更健康更实用的健康产品。江中制药旗下的P9益生菌冻 干粉，凭借深厚的品牌积淀、硬核的科研成果与扎实的产品实力，成为今年春节年礼的代表作，以中国 航天事业合作伙伴的身份，拥有非同寻常的"航天级品质"与健康分量。 在益生菌行业，一直有"中国菌更适合中国肠胃"的共识。国人的饮 ...

Market Overview - The global probiotic market reached a size of $60.23 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 8.7%, potentially reaching $93.49 billion by 2028 [3] - The Chinese probiotic market surpassed 100 billion yuan in 2022, reaching 106.5 billion yuan, with expectations to grow to 137.7 billion yuan by 2026 [3] Company Insights - Jiangzhong has been recognized as the "No. 1 in China for probiotic freeze-dried powder sales" in 2024, indicating strong market performance [6] - The company focuses on gut health with its P9 probiotic freeze-dried powder, which includes 19 strains of probiotics, enhancing gut flora and promoting the proliferation of beneficial bacteria [7] Product Development - The core strain, Lactobacillus plantarum P9, has undergone eight years of research and has been clinically validated for its effectiveness in regulating gut microbiota and improving conditions like constipation and chronic diarrhea [7][9] - Jiangzhong employs advanced encapsulation technology and liquid nitrogen freezing to enhance the survival rate of probiotics during transport and digestion, ensuring their effectiveness upon reaching the gut [9]